Multitargeted Therapies for Multiple Myeloma

Autophagy - United States
doi 10.4161/auto.22738
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Chimeric Antigen Receptor T Cell Therapies for Multiple Myeloma

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

Novel Therapies in Multiple Myeloma for Newly Diagnosed Nontransplant Candidates

Cancer Journal
Cancer ResearchOncology
2009English

CHIR-258, a Novel, Multitargeted Tyrosine Kinase Inhibitor for the Potential Treatment of T(4;14) Multiple Myeloma

Blood
BiochemistryImmunologyCell BiologyHematology
2005English

Pcn311 - European Market Access Challenges for Relapsed Refractory Multiple Myeloma Triplet Therapies

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Multiple Myeloma

Annals of Internal Medicine
Internal MedicineMedicine
1942English

Multiple Myeloma

Bone Marrow Transplantation
TransplantationHematology
2000English

Psy63 - Cost by Outcomes Analysis of Novel Triple-Combination Therapies for Relapsed/Refractory Multiple Myeloma in Brazil

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Multiple Myeloma

Cancer Imaging
Nuclear MedicineRadiologyUltrasound TechnologyOncologyRadiologicalImagingMedicine
2004English

Chromosome 1 Abnormalities in Elderly Patients With Newly Diagnosed Multiple Myeloma Treated With Novel Therapies

Haematologica
Hematology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy